Several studies have found associations between excessive JAK-STAT signaling activation in prostate cancer and the regulation of lineage plasticity, resistance to AR-targeted therapies, and poor clinical outcomes.309,310 JAK1, JAK2, STAT1, and STAT3 are essential drivers of lineage plasticity in cancer cells. The gene discussed is AR; the disease is prostate carcinoma.